$35 month­ly in­sulin cap: Re­pub­li­cans de­cry how White House, Dems plan to pay for it

As the House preps to vote on a $35 month­ly in­sulin cap lat­er to­day (the Sen­ate has plans for a vote next month too), there re­main sev­er­al out­stand­ing ques­tions on how the unin­sured will be cov­ered, how De­moc­rats plan to pay for the cap and what the af­ter-ef­fects might be (i.e. will this cap be off­set by pre­mi­um in­creas­es?).

Kick­ing off dis­cus­sion on the White House-backed cap Wednes­day, the House Rules Com­mit­tee split al­most even­ly along par­ty lines. De­moc­rats called for some­thing to be done to stop peo­ple from ra­tioning their life­sav­ing in­sulin due to price, while Re­pub­li­cans have sought oth­er plans to low­er in­sulin costs, in­clud­ing mar­ket-based so­lu­tions like biosim­i­lars, which have strug­gled to take off so far, or pro­vid­ing PBM re­bates di­rect­ly to pa­tients.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN